119 related articles for article (PubMed ID: 2542329)
21. Effects of erythroid differentiation factor (EDF) on proliferation and differentiation of human hematopoietic progenitors.
Nakao K; Kosaka M; Saito S
Exp Hematol; 1991 Dec; 19(11):1090-5. PubMed ID: 1752318
[TBL] [Abstract][Full Text] [Related]
22. Induction of differentiation of the human promyelocytic cell line HL-60 by activin/EDF.
Yamada R; Suzuki T; Hashimoto M; Eto Y; Shiokawa K; Muramatsu M
Biochem Biophys Res Commun; 1992 Aug; 187(1):79-85. PubMed ID: 1325796
[TBL] [Abstract][Full Text] [Related]
23. Interaction of two cytoplasmic erythroid differentiation-inducing factors in mouse erythroleukemia cells.
Watanabe T; Oishi M
Cell Growth Differ; 1992 Dec; 3(12):865-71. PubMed ID: 1472466
[TBL] [Abstract][Full Text] [Related]
24. Phorbol ester-treated human acute myeloid leukemia cells secrete G-CSF, GM-CSF and erythroid differentiation factor into serum-free media in primary culture.
Scher W; Eto Y; Ejima D; Den T; Svet-Moldavsky IA
Biochim Biophys Acta; 1990 Dec; 1055(3):278-86. PubMed ID: 1702323
[TBL] [Abstract][Full Text] [Related]
25. Recombinant bone morphogenetic protein-4, transforming growth factor-beta 1, and activin A enhance the cartilage phenotype of articular chondrocytes in vitro.
Luyten FP; Chen P; Paralkar V; Reddi AH
Exp Cell Res; 1994 Feb; 210(2):224-9. PubMed ID: 8299720
[TBL] [Abstract][Full Text] [Related]
26. Effect of erythroid differentiation factor on maintenance of human hematopoietic cells in co-cultures with allogenic stromal cells.
Nakamura K; Kosaka M; Mizuguchi T; Saito S
Biochem Biophys Res Commun; 1993 Aug; 194(3):1103-10. PubMed ID: 8352765
[TBL] [Abstract][Full Text] [Related]
27. Evidence for the participation of endogenous activin A/erythroid differentiation factor in the regulation of erythropoiesis.
Shiozaki M; Sakai R; Tabuchi M; Nakamura T; Sugino K; Sugino H; Eto Y
Proc Natl Acad Sci U S A; 1992 Mar; 89(5):1553-6. PubMed ID: 1542647
[TBL] [Abstract][Full Text] [Related]
28. In vivo treatment with erythroid differentiation factor (EDF/activin A) increases erythroid precursors (CFU-E and BFU-E) in mice.
Shiozaki M; Sakai R; Tabuchi M; Eto Y; Kosaka M; Shibai H
Biochem Biophys Res Commun; 1989 Dec; 165(3):1155-61. PubMed ID: 2610684
[TBL] [Abstract][Full Text] [Related]
29. Induction of erythropoietin receptors during aclacinomycin-mediated erythroid differentiation of K562 leukemia cells.
Jeannesson P; Trentesaux C; Nyoung MN; Mayeux P; Jacquot R; Jardillier JC
Leukemia; 1991 Jan; 5(1):14-8. PubMed ID: 1847982
[TBL] [Abstract][Full Text] [Related]
30. Characterization of the activin receptor in cultured rat hepatocytes.
Zhang YQ; Kanzaki M; Mashima H; Mine T; Kojima I
Hepatology; 1996 Aug; 24(2):446-50. PubMed ID: 8690418
[TBL] [Abstract][Full Text] [Related]
31. Characterization of the receptor for keratinocyte growth factor. Evidence for multiple fibroblast growth factor receptors.
Bottaro DP; Rubin JS; Ron D; Finch PW; Florio C; Aaronson SA
J Biol Chem; 1990 Aug; 265(22):12767-70. PubMed ID: 2165484
[TBL] [Abstract][Full Text] [Related]
32. The erythropoietin receptor of rat erythroid progenitor lens. Characterization and affinity cross-linkage.
Mayeux P; Billat C; Jacquot R
J Biol Chem; 1987 Oct; 262(29):13985-90. PubMed ID: 2820989
[TBL] [Abstract][Full Text] [Related]
33. Expression and processing of the activin-A/erythroid differentiation factor precursor: a member of the transforming growth factor-beta superfamily.
Huylebroeck D; Van Nimmen K; Waheed A; von Figura K; Marmenout A; Fransen L; De Waele P; Jaspar JM; Franchimont P; Stunnenberg H
Mol Endocrinol; 1990 Aug; 4(8):1153-65. PubMed ID: 1963471
[TBL] [Abstract][Full Text] [Related]
34. Murine interleukin 7 (IL-7) receptor. Characterization on an IL-7-dependent cell line.
Park LS; Friend DJ; Schmierer AE; Dower SK; Namen AE
J Exp Med; 1990 Apr; 171(4):1073-89. PubMed ID: 2324686
[TBL] [Abstract][Full Text] [Related]
35. Effects of transforming growth factor-beta and activin A on vitamin D3-induced monocytic differentiation of myeloid leukemia cells.
Okabe-Kado J; Honma Y; Hayashi M; Hozumi M
Anticancer Res; 1991; 11(1):181-6. PubMed ID: 2018352
[TBL] [Abstract][Full Text] [Related]
36. Down-modulation of c-kit mRNA and protein expression by erythroid differentiation factor/activin A.
Hino M; Nishizawa Y; Tatsumi N; Tojo A; Morii H
FEBS Lett; 1995 Oct; 374(1):69-71. PubMed ID: 7589515
[TBL] [Abstract][Full Text] [Related]
37. Inhibin antagonizes inhibition of liver cell growth by activin by a dominant-negative mechanism.
Xu J; McKeehan K; Matsuzaki K; McKeehan WL
J Biol Chem; 1995 Mar; 270(11):6308-13. PubMed ID: 7890768
[TBL] [Abstract][Full Text] [Related]
38. Identification of the receptor for erythropoietin on human and murine erythroleukemia cells and modulation by phorbol ester and dimethyl sulfoxide.
Broudy VC; Lin N; Egrie J; de Haën C; Weiss T; Papayannopoulou T; Adamson JW
Proc Natl Acad Sci U S A; 1988 Sep; 85(17):6513-7. PubMed ID: 2842774
[TBL] [Abstract][Full Text] [Related]
39. Activin and inhibin binding to the soluble extracellular domain of activin receptor II.
Donaldson CJ; Vaughan JM; Corrigan AZ; Fischer WH; Vale WW
Endocrinology; 1999 Apr; 140(4):1760-6. PubMed ID: 10098513
[TBL] [Abstract][Full Text] [Related]
40. Preferential binding of insulin-like growth factor-II (IGF-II) to a putative alpha 2 beta 2 IGF-II receptor type in C2 myoblasts.
Domeyne A; Pinset C; Montarras D; Garandel V; Rosenfeld RG; Barenton B
Eur J Biochem; 1992 Sep; 208(2):273-9. PubMed ID: 1325901
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
